Note 12 Stock-Based Compensation

6 Months Ended

Mar. 29, 2014

Share-based Compensation [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Stock-Based Compensation

Stock-based compensation expense was attributable to:

	Three Months Ended				Six Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
	(In thousands)
Stock options	$	2,886	$	2,757	$	5,358	$	5,374
Restricted stock units	1,871		1,585		3,674		3,634
Total	$	4,757	$	4,342	$	9,032	$	9,008

Stock-based compensation expense was recognized as follows:

	Three Months Ended				Six Months Ended
	March 29, 2014		March 30, 2013		March 29, 2014		March 30, 2013
	(In thousands)
Cost of sales	$	1,364	$	1,291	$	2,565	$	2,631
Selling, general and administrative	3,382		3,004		6,454		6,299
Research and development	11		47		13		78
Total	$	4,757	$	4,342	$	9,032	$	9,008

During the second quarter of 2014, the Company's stockholders approved the reservation of an additional 1.7 million million shares of common stock for future issuance under the Company's 2009 Incentive Plan. As of March 29, 2014, an aggregate of 15.1 million shares were authorized for future issuance under the Company's stock plans, of which 11.4 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3.7 million shares of common stock were available for future grant.

Stock Options

Stock option activity was as follows:

	Number of Shares		Weighted- Average Exercise Price ($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value of In-The-Money Options ($)
	(In thousands)				(In thousands)
Outstanding, September 28, 2013	9,562		12.65	5.99	62,825
Granted	562		15.64
Exercised/Cancelled/Forfeited/Expired	(711	)	13.24
Outstanding, March 29, 2014	9,413		12.78	5.73	53,331
Vested and expected to vest, March 29, 2014	9,179		12.82	5.66	52,026
Exercisable, March 29, 2014	7,311		13.15	4.95	42,113

The weighted-average grant date fair value of stock options granted during the three and six months ended March 29, 2014 was $9.04 per share and $9.18 per share, respectively. The aggregate intrinsic value in the preceding table represents the total pre-tax intrinsic value of in-the-money options that would have been received by the option holders had all option holders exercised their options at the Company's closing stock price on the date indicated.

As of March 29, 2014, unrecognized compensation expense of $13.6 million is expected to be recognized over a weighted average period of 2.2 years.

Restricted Stock Units

Activity with respect to the Company's restricted stock units was as follows:

	Number of Shares		Weighted- Average Grant Date Fair Value ($)	Weighted- Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value ($)
	(In thousands)				(In thousands)
Outstanding, September 28, 2013	1,768		10.90	2.02	31,052
Granted	746		15.63
Vested/Forfeited/Cancelled	(566	)	13.71
Outstanding, March 29, 2014	1,948		11.90	2.41	32,803
Expected to vest, March 29, 2014	969		11.31	2.13	16,311

As of March 29, 2014, unrecognized compensation expense of $10.4 million is expected to be recognized over a weighted average period of 1.9 years. Additionally, as of March 29, 2014, unrecognized compensation expense related to performance-based restricted stock units was $9.1 million. To date, no expense has been recorded for these performance-based restricted stock units as achievement of the performance criteria is not considered probable.